Literature DB >> 29525394

A population-based cohort study defines prognoses in severe chronic kidney disease.

Marcello Tonelli1, Natasha Wiebe2, Matthew T James3, Scott W Klarenbach2, Braden J Manns3, Pietro Ravani3, Giovanni F M Strippoli4, Brenda R Hemmelgarn3.   

Abstract

In older people with chronic kidney disease (CKD) and comorbidities, the risk of death or disability may overshadow the risk of kidney failure. To help refine this we did a retrospective population-based cohort study to evaluate the relative likelihood of adverse outcomes as functions of age and comorbidity burden among 47,228 adults with severe non-dialysis dependent CKD. We identified comorbidities using 29 validated algorithms applied to administrative data and assessed death, end-stage renal disease (ESRD), cardiovascular disease (CVD) events, and long-term care. Over five years of follow-up, 53.4% of participants died, 24.1% had a CVD event, 14.3% were placed into long-term care and 5.3% developed ESRD. Death was 145 times more likely and 11 times more likely than ESRD for participants aged 80 years or more and 60-79 years, respectively; long-term care was 30 times more likely and 1.7 times as likely as ESRD for participants aged 80 years or more and 60-79 years, respectively. Increasing comorbidity burden was similarly associated with increased risk of death and long-term care placement but reduced the likelihood of ESRD, and the risks of increasing age were similarly incremental. Thus, among patients with severe CKD, older age and/or higher comorbidity burden, death and long-term care placement are markedly more likely than ESRD. Hence, clinicians, patients and families should all consider the relative magnitude of these risks when making decisions about renal replacement.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  albuminuria; chronic kidney disease; prognosis

Mesh:

Year:  2018        PMID: 29525394     DOI: 10.1016/j.kint.2017.12.013

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Quantification of Inflammasome Adaptor Protein ASC in Biological Samples by Multiple-Reaction Monitoring Mass Spectrometry.

Authors:  Annegret Ulke-Lemée; Arthur Lau; Michelle C Nelson; Matthew T James; Daniel A Muruve; Justin A MacDonald
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Serious Illness Treatment Preferences for Older Adults with Advanced CKD.

Authors:  Nicolas Awad Baddour; Edward D Siew; Cassianne Robinson-Cohen; Huzaifah Salat; Olivia J Mason; Thomas G Stewart; Mohana Karlekar; Maie H El-Sourady; Loren Lipworth; Khaled Abdel-Kader
Journal:  J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 10.121

3.  The Surprise Question and Self-Rated Health Are Useful Screens for Frailty and Disability in Older Adults with Chronic Kidney Disease.

Authors:  Nicolas A Baddour; Cassianne Robinson-Cohen; Loren Lipworth; Aihua Bian; Thomas G Stewart; Manisha Jhamb; Edward D Siew; Khaled Abdel-Kader
Journal:  J Palliat Med       Date:  2019-06-28       Impact factor: 2.947

4.  Nomogram Model Based on Clinical Risk Factors and Heart Rate Variability for Predicting All-Cause Mortality in Stage 5 CKD Patients.

Authors:  Xueyan Gao; Jing Wang; Hui Huang; Xiaoxue Ye; Ying Cui; Wenkai Ren; Fangyan Xu; Hanyang Qian; Zhanhui Gao; Ming Zeng; Guang Yang; Yaoyu Huang; Shaowen Tang; Changying Xing; Huiting Wan; Lina Zhang; Huimin Chen; Yao Jiang; Jing Zhang; Yujie Xiao; Anning Bian; Fan Li; Yongyue Wei; Ningning Wang
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

5.  Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 CKD.

Authors:  Pietro Ravani; Marta Fiocco; Ping Liu; Robert R Quinn; Brenda Hemmelgarn; Matthew James; Ngan Lam; Braden Manns; Matthew J Oliver; Giovanni F M Strippoli; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 10.121

6.  Incidence of Uncommon Clinical Events in USA Patients with Dialysis-Dependent and Nondialysis-Dependent Chronic Kidney Disease: Analysis of Electronic Health Records from TriNetX.

Authors:  Alyshah Abdul Sultan; Glen James; Xia Wang; Seth Kuranz; Katarina Hedman; Mark Houser; Syed Asif Haque; Dustin Little
Journal:  Nephron       Date:  2021-06-03       Impact factor: 2.847

7.  Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.

Authors:  Marcello Tonelli; Natasha Wiebe; Csaba P Kovesdy; Matthew T James; Scott W Klarenbach; Braden J Manns; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2019-06-06       Impact factor: 2.388

8.  Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada.

Authors:  Pietro Ravani; Rob Quinn; Marta Fiocco; Ping Liu; Huda Al-Wahsh; Ngan Lam; Brenda R Hemmelgarn; Braden J Manns; Matthew T James; Yves Joanette; Marcello Tonelli
Journal:  JAMA Netw Open       Date:  2020-09-01

9.  Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.

Authors:  Manon J M van Oosten; Susan J J Logtenberg; Martijn J H Leegte; Henk J G Bilo; Sigrid M Mohnen; Leona Hakkaart-van Roijen; Marc H Hemmelder; G Ardine de Wit; Kitty J Jager; Vianda S Stel
Journal:  Nephrol Dial Transplant       Date:  2020-12-04       Impact factor: 5.992

10.  Mortality and Resource Use Among Individuals With Chronic Kidney Disease or Cancer in Alberta, Canada, 2004-2015.

Authors:  Marcello Tonelli; Anita Lloyd; Winson Y Cheung; Brenda R Hemmelgarn; Matthew T James; Pietro Ravani; Braden Manns; Scott W Klarenbach
Journal:  JAMA Netw Open       Date:  2022-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.